Our group has explored the prophylactic and therapeutic potential of a DNA vaccine containing the gene of a heat shock protein from Mycobacterium leprae (DNA-HSP65) in experimental tuberculosis [25-28]. The gene discussed is HSPD1; the disease is tuberculosis.